Drug:
Reaction: ERYTHEMA
20250101 - 20251231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 25085877 |
US |
48 | 2 |
Blood pressure increased, Swelling face, Erythema, Swelling, |
||||
BUDESONIDE, ALBUTEROL SULFATE, ALBUTEROL, CALCIUM CARBONATE, ANTACID, ERGOCALCIFEROL, EMPAGLIFLOZIN, ERYTHROPOIETIN, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, FOLIC ACID, SIMVASTATIN, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 402 | 25085987 |
PY |
||
Lip oedema, Erythema, Cervix erythema, Dizziness, Dysgeusia, Hypoaesthesia oral, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 403 | 25086028 |
FR |
72 | 2 |
Erythema, Off label use, |
||||
CARBOPLATIN, PACLITAXEL, CETUXIMAB, |
||||
| 404 | 25086361 |
US |
69 | 1 |
Eczema, Rash papular, Erythema, |
||||
CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, |
||||
| 405 | 25086374 |
US |
81 | 1 |
Erythema, Hot flush, |
||||
FLUTEMETAMOL F-18, |
||||
| 406 | 25086381 |
CA |
86 | 2 |
Erythema, Breast cancer, Abdominal distension, Herpes zoster, Infection, Diarrhoea, |
||||
MEPOLIZUMAB, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, MONTELUKAST SODIUM, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 407 | 25086583 |
BR |
53 | 2 |
Infarction, Pruritus, Injection site haemorrhage, Blister, Erythema, Mass, Surgery, |
||||
RISANKIZUMAB-RZAA, |
||||
| 408 | 25081269 |
US |
3 | 2 |
Erythema, Skin exfoliation, Injection site pain, |
||||
DUPILUMAB, |
||||
| 409 | 25081335 |
US |
68 | 2 |
Influenza, Pain, Back pain, Fatigue, Therapeutic response shortened, Dyspnoea, Oxygen saturation decreased, Musculoskeletal discomfort, Bronchitis, Skin exfoliation, Erythema, Rash, |
||||
DUPILUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 410 | 25081387 |
DE |
50 | 2 |
Anaphylactic shock, Hypotension, Tachycardia, Dyskinesia, Erythema, Body temperature increased, Breath sounds abnormal, |
||||
CEFUROXIME, PROPOFOL, SUFENTANIL, |
||||
| 411 | 25081508 |
US |
26 | 2 |
Pruritus, Erythema, |
||||
INSULIN LISPRO, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 412 | 25085994 |
21 | 1 | |
Erythema, Swelling, |
||||
| 413 | 25080481 |
US |
2 | |
Dermatitis atopic, Erythema, |
||||
DUPILUMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, |
||||
| 414 | 25080584 |
US |
59 | 2 |
Pain, Erythema, Contusion, |
||||
INSULIN GLARGINE, INSULIN ASPART INJECTION, INSULIN ASPART, |
||||
| 415 | 25080647 |
US |
75 | 2 |
Swelling face, Erythema, Eye swelling, Ocular hyperaemia, Skin burning sensation, Eye irritation, |
||||
DUPILUMAB, |
||||
| 416 | 25080712 |
US |
81 | 2 |
Erythema, Application site warmth, Dermatitis contact, Application site pruritus, |
||||
OXYBUTYNIN, LEVOTHYROXINE, OMEPRAZOLE MAGNESIUM, |
||||
| 417 | 25081023 |
US |
40 | 2 |
Nasal congestion, Flushing, Acne, Skin swelling, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 418 | 25077180 |
US |
17 | 2 |
Eczema, Therapeutic response shortened, Erythema, Skin fissures, Skin erosion, Condition aggravated, Product storage error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 419 | 25077186 |
US |
54 | 2 |
Periorbital swelling, Nasal congestion, Pruritus, Erythema, Swelling face, |
||||
DUPILUMAB, DUPILUMAB, DESONIDE, FLUTICASONE PROPIONATE, PROGESTERONE, MOMETASONE FUROATE, |
||||
| 420 | 25077394 |
US |
6 | 1 |
Ocular hyperaemia, Erythema, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 421 | 25077481 |
DE |
77 | 1 |
Gastritis, Erythema, Akinesia, Confusional state, Catheter site pain, Infusion site erythema, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 422 | 25077484 |
ES |
60 | 2 |
Erythema, Skin irritation, Product adhesion issue, Incorrect dose administered, |
||||
ROTIGOTINE, ROTIGOTINE, ROTIGOTINE, |
||||
| 423 | 25077506 |
IT |
47 | 2 |
Bronchospasm, Erythema, Myalgia, Hypoaesthesia, Throat tightness, |
||||
SIMVASTATIN, |
||||
| 424 | 25077585 |
PL |
47 | 2 |
Erythema, Dyspnoea, |
||||
CARBOPLATIN, |
||||
| 425 | 25077614 |
US |
38 | 1 |
Injection site discharge, Erythema, Product quality issue, |
||||
ADALIMUMAB, |
||||
| 426 | 25077797 |
CN |
64 | 1 |
Laryngeal oedema, Erythema, Urticaria, Pruritus, Drug hypersensitivity, Infusion related reaction, |
||||
DARATUMUMAB, BORTEZOMIB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 427 | 25078275 |
CA |
||
Erythema, Dyspnoea, Throat tightness, Hypoaesthesia, Anxiety, Vomiting, Nausea, Headache, Blood pressure fluctuation, Heart rate increased, Off label use, Intentional product use issue, Off label use, Drug level decreased, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 428 | 25078384 |
US |
54 | 1 |
Erythema, Pruritus, Skin burning sensation, |
||||
ABATACEPT, |
||||
| 429 | 25078542 |
FR |
69 | 2 |
Pain, Erythema, Extravasation, |
||||
OXALIPLATIN, |
||||
| 430 | 25078553 |
TW |
53 | 1 |
Dyspnoea, Erythema, Drug hypersensitivity, |
||||
SUGAMMADEX, |
||||
| 431 | 25078600 |
US |
2 | |
Erythema, Rash, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 432 | 25078615 |
US |
1 | |
Eczema, Pruritus, Insomnia, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 433 | 25078631 |
US |
15 | 1 |
Salivary hypersecretion, Erythema, |
||||
DUPILUMAB, |
||||
| 434 | 25078792 |
CN |
79 | 1 |
Anaphylactic shock, Chest discomfort, Erythema, |
||||
| 435 | 25079125 |
JP |
||
Erythema, Oropharyngeal pain, Injection site urticaria, |
||||
| 436 | 25079175 |
FR |
57 | 2 |
Erythema, |
||||
AMOXICILLIN, |
||||
| 437 | 25079264 |
US |
18 | 2 |
Flushing, Paraesthesia oral, Palpitations, Dyspnoea, Tachycardia, Erythema, Hypotension, Hypersensitivity, Dizziness, Off label use, Injection site scar, Injection site urticaria, |
||||
ALBUTEROL SULFATE, ALBUTEROL, BACLOFEN, CELECOXIB, ERGOCALCIFEROL, POLYETHYLENE GLYCOL 3350, PANTOPRAZOLE SODIUM, RIZATRIPTAN, CETIRIZINE HYDROCHLORIDE, |
||||
| 438 | 25079363 |
IT |
80 | 2 |
Erythema, Rash pustular, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 439 | 25079407 |
US |
51 | 2 |
Blindness unilateral, Paraesthesia, Hot flush, Eye swelling, Erythema, Pruritus, Pain, Conjunctivitis, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 440 | 25079411 |
CA |
52 | 2 |
Abdominal discomfort, Body temperature decreased, Contusion, Cystitis, Drug hypersensitivity, Erythema, Headache, Heart rate increased, Hypotension, Migraine, Poor venous access, Somnolence, |
||||
FENTANYL, OCRELIZUMAB, OCRELIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 441 | 25079524 |
US |
||
Adverse event, Scratch, Erythema, |
||||
| 442 | 25079660 |
US |
27 | 1 |
Erythema, |
||||
DUPILUMAB, |
||||
| 443 | 25079859 |
CN |
66 | 2 |
Blood pressure decreased, Cough, Erythema, Abdominal discomfort, Heart rate increased, |
||||
IOPROMIDE, |
||||
| 444 | 25080007 |
US |
78 | |
Dyspnoea, Erythema, Flushing, |
||||
FLUTEMETAMOL F-18, |
||||
| 445 | 25080010 |
US |
72 | 2 |
Dyspnoea, Urticaria, Erythema, |
||||
IOHEXOL, |
||||
| 446 | 25083989 |
72 | 2 | |
Peripheral swelling, Erythema, Peripheral vein thrombosis, |
||||
LENALIDOMIDE, |
||||
| 447 | 25071873 |
US |
35 | 1 |
Dermatitis, Eczema, Pruritus, Erythema, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 448 | 25071888 |
US |
1 | |
Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 449 | 25072179 |
US |
58 | 2 |
Alopecia, Eczema, Pruritus, Erythema, Skin exfoliation, Skin haemorrhage, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 450 | 25072194 |
ES |
58 | 1 |
Erythema, Malaise, Face oedema, Urticaria, Pruritus, |
||||
ROSUVASTATIN, |
||||
| 451 | 25072199 |
US |
2 | |
Infusion site vesicles, Erythema, Feeling hot, |
||||
EPOPROSTENOL, AMBRISENTAN, TREPROSTINIL, SILDENAFIL CITRATE, SILDENAFIL, FAMOTIDINE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREDNISONE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, ERGOCALCIFEROL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, PRAVASTATIN SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, EPOPROSTENOL, TREPROSTINIL, SILDENAFIL CITRATE, SILDENAFIL, SPIRONOLACTONE, |
||||
| 452 | 25072221 |
US |
13 | 2 |
Alopecia, Eczema, Erythema, Pruritus, Condition aggravated, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 453 | 25072359 |
US |
69 | 2 |
Pruritus, Erythema, |
||||
SARILUMAB, |
||||
| 454 | 25072381 |
IR |
37 | 2 |
Escherichia infection, Necrotising fasciitis, Erythema, C-reactive protein increased, Osteomyelitis, Osteonecrosis, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, HYDROXYCHLOROQUINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, NAPROXEN, NAPROXEN SODIUM, |
||||
| 455 | 25072440 |
US |
||
Rash macular, Erythema, Drug hypersensitivity, |
||||
PIMAVANSERIN TARTRATE, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, |
||||
| 456 | 25072524 |
US |
5 | 1 |
Overdose, Erythema, Skin haemorrhage, Product storage error, Injection site pain, Rash, Intentional product misuse, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, CRISABOROLE, |
||||
| 457 | 25072543 |
US |
44 | 1 |
Headache, Pruritus, Erythema, |
||||
| 458 | 25072620 |
SE |
56 | 2 |
Neuropathy peripheral, Erythema, Dysaesthesia, Skin burning sensation, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 459 | 25072673 |
DE |
2 | |
Gastrointestinal haemorrhage, Urticaria, Erythema, Rash, Blister, Oedema, |
||||
| 460 | 25072773 |
HR |
2 | |
Deep vein thrombosis, Rash, Erythema, Induration, Peripheral swelling, |
||||
FREMANEZUMAB-VFRM, |
||||
| 461 | 25072844 |
ES |
58 | 1 |
Erythema, Swelling, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, BISOPROLOL FUMARATE, GLIMEPIRIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, RAMIPRIL, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 462 | 25073008 |
US |
70 | 2 |
Disease progression, Product odour abnormal, Drug ineffective, Erythema, |
||||
IVERMECTIN, |
||||
| 463 | 25073093 |
US |
25 | 1 |
Erythema, Rash, |
||||
DUPILUMAB, |
||||
| 464 | 25073128 |
CA |
49 | 2 |
Constipation, Erythema, Eye irritation, Eye pain, Eye pruritus, Eye swelling, Hypoaesthesia, Lip swelling, Pruritus, Rash macular, Swelling, Swelling face, Angioedema, Fatigue, Headache, Urticaria, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, |
||||
| 465 | 25073140 |
DE |
72 | 1 |
Immune-mediated adverse reaction, Chemotherapy, Hepatitis, Rhabdomyolysis, Myocarditis, Myositis, Dysphagia, Dysphonia, Erythema, Eczema, Therapy partial responder, |
||||
PEMBROLIZUMAB, ENFORTUMAB VEDOTIN, |
||||
| 466 | 25073182 |
DE |
50 | 2 |
Anaphylactic shock, Body temperature increased, Breath sounds abnormal, Dyskinesia, Hypotension, Erythema, Tachycardia, |
||||
CEFUROXIME AXETIL, PROPOFOL, SUFENTANIL, |
||||
| 467 | 25073253 |
US |
46 | 1 |
Alopecia, Erythema, Inappropriate schedule of product administration, Overdose, Suspected counterfeit product, |
||||
| 468 | 25073433 |
US |
4 | 2 |
Dermatitis atopic, Erythema, Nipple pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 469 | 25073455 |
US |
62 | |
Metastases to central nervous system, Metastases to lymph nodes, Metastases to chest wall, Erythema, Vocal cord paralysis, Cough, Dry throat, Dysphonia, |
||||
OSIMERTINIB, |
||||
| 470 | 25073504 |
US |
16 | 2 |
Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 471 | 25073593 |
CA |
26 | 2 |
Urticaria, Anaphylactic reaction, Angioedema, Blood pressure increased, COVID-19, Condition aggravated, Contusion, Cough, Erythema, Fatigue, Headache, Heart rate increased, Illness, Immunodeficiency, Injection site pain, Insomnia, Ligament sprain, Loss of consciousness, Malaise, Menstrual disorder, Migraine, Musculoskeletal stiffness, Nasopharyngitis, Obstructive airways disorder, Off label use, Oropharyngeal pain, Pain, Peripheral swelling, Pharyngitis streptococcal, Pruritus, Respiratory arrest, Sensitivity to weather change, Sinus congestion, Sinusitis, Skin burning sensation, Sleep apnoea syndrome, Stress, Swelling, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DUPILUMAB, GABAPENTIN, MEDROXYPROGESTERONE ACETATE, PREDNISONE, BUPROPION HYDROCHLORIDE, DESVENLAFAXINE, DESVENLAFAXINE SUCCINATE, |
||||
| 472 | 25073641 |
US |
||
Eyelid oedema, Rash, Erythema, Product use in unapproved indication, |
||||
TRETINOIN, TRETINOIN, |
||||
| 473 | 25073675 |
US |
||
Flushing, Erythema, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 474 | 25073977 |
CA |
||
Arthralgia, Pruritus, Skin burning sensation, Shock, Pustule, Mental disorder, Aphonia, Product dose omission issue, Myalgia, Alopecia, Back pain, Ligament sprain, Injection site pain, Pain, General physical condition abnormal, Influenza, Pain in extremity, Peripheral swelling, Burning sensation, Nausea, Weight increased, Diarrhoea, Somnolence, Urticaria, Blood pressure systolic increased, Fatigue, Bronchitis, COVID-19, Erythema, Feeling abnormal, Gait inability, Ill-defined disorder, Insomnia, Musculoskeletal stiffness, Osteoarthritis, Pyrexia, Skin plaque, Therapy partial responder, Swelling, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, LORAZEPAM, LORAZEPAM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, TIMOLOL, |
||||
| 475 | 25074022 |
US |
2 | |
Malaise, Skin burning sensation, Gingival pain, Erythema, Toothache, Fatigue, Feeling abnormal, |
||||
RISANKIZUMAB-RZAA, LORAZEPAM, DIPHENHYDRAMINE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, LEVOTHYROXINE, |
||||
| 476 | 25074111 |
US |
42 | 2 |
Erythema, Skin exfoliation, Pruritus, Injection site pruritus, Injection site haemorrhage, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 477 | 25074266 |
US |
57 | 2 |
Vasodilatation, Vascular compression, Erythema, Carpal tunnel syndrome, |
||||
CLADRIBINE, CLADRIBINE, |
||||
| 478 | 25074364 |
ES |
70 | 1 |
Peritonitis, Chronic kidney disease, Malignant neoplasm progression, Eczema eyelids, Anal inflammation, Erythema, Dermatitis acneiform, Stomatitis, Rash, Proteinuria, Asthenia, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ALLOPURINOL, FOLIC ACID, PARICALCITOL, |
||||
| 479 | 25074483 |
US |
2 | |
Flushing, Erythema, Back pain, |
||||
TREPROSTINIL, TREPROSTINIL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ATORVASTATIN CALCIUM, SERTRALINE HYDROCHLORIDE, TADALAFIL, METOLAZONE, FLUTICASONE PROPIONATE, WARFARIN SODIUM, WARFARIN, BUMETANIDE, SPIRONOLACTONE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, AMBRISENTAN, |
||||
| 480 | 25074618 |
ES |
74 | 1 |
Hypotension, Pruritus, Erythema, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 481 | 25074696 |
US |
24 | 2 |
Loss of consciousness, Lip dry, Skin discomfort, Sensitive skin, Condition aggravated, Brain fog, Depression, Anxiety, Rash macular, Erythema, Meibomian gland dysfunction, Rash, |
||||
ISOTRETINOIN, ISOTRETINOIN, |
||||
| 482 | 25074702 |
ES |
29 | 1 |
Palpitations, Dyspnoea, Erythema, Dizziness, |
||||
CABOTEGRAVIR SODIUM, |
||||
| 483 | 25074715 |
IT |
43 | 2 |
Malaise, Erythema, Pruritus, |
||||
AMOXICILLIN, |
||||
| 484 | 25074890 |
US |
70 | 2 |
Inflammation, Erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 485 | 25074892 |
CA |
49 | 2 |
Perichondritis, Erythema, Swelling, Ear pain, |
||||
SECUKINUMAB, |
||||
| 486 | 25075317 |
ES |
15 | 1 |
Erythema, Erythema, Lip oedema, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 487 | 25075552 |
2 | ||
Erythema, Pruritus, Skin burning sensation, Therapy interrupted, Osteomyelitis, |
||||
IXEKIZUMAB, BENRALIZUMAB, |
||||
| 488 | 25075857 |
KR |
||
Oesophagitis, Vomiting, Fatigue, Chest discomfort, Chest pain, Blood pressure systolic increased, Dyspepsia, Dizziness, Amnesia, Pruritus, Acne, Erythema, Pruritus, Haematuria, Acne, Urticaria, Pruritus, Paraesthesia, Erythema, |
||||
OSIMERTINIB, |
||||
| 489 | 25076080 |
CH |
62 | 2 |
Vancomycin infusion reaction, Flushing, Erythema, Rash maculo-papular, Rash, |
||||
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
| 490 | 25076257 |
US |
59 | 1 |
Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 491 | 25076558 |
JP |
7 | 2 |
Malignant neoplasm progression, Postrenal failure, Proteinuria, Polydipsia, Vaginal prolapse, Hypertension, Erythema, Hyponatraemia, Decreased appetite, Drug ineffective, |
||||
PEMBROLIZUMAB, |
||||
| 492 | 25078176 |
16 | 2 | |
Throat irritation, Dyspnoea, Erythema, Infusion related reaction, |
||||
INFLIXIMAB-AXXQ, |
||||
| 493 | 25066130 |
US |
||
Herpes ophthalmic, Photophobia, Eye discharge, Periorbital swelling, Erythema, |
||||
HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, PREDNISONE, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 494 | 25066141 |
CA |
||
Flushing, Erythema, Pyrexia, Underdose, |
||||
RITUXIMAB, RITUXIMAB, |
||||
| 495 | 25066188 |
US |
18 | 2 |
Erythema, Erythema, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 496 | 25066393 |
ES |
76 | 2 |
Urinary tract infection, Erythema, Dehydration, Renal disorder, Hallucination, Constipation, Dermatitis allergic, |
||||
RIVASTIGMINE, |
||||
| 497 | 25066609 |
BR |
2 | |
Drug dependence, Depression, Mental disorder, Erythema, Swelling, Pruritus, Product availability issue, |
||||
OMALIZUMAB, |
||||
| 498 | 25067134 |
GB |
70 | 1 |
Tachycardia, Loss of consciousness, Erythema, Cold sweat, |
||||
HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 499 | 25067333 |
CA |
36 | 1 |
Abdominal hernia, Allergy to animal, Anxiety, Balance disorder, Blood pressure increased, Cardiac disorder, Cough, Decreased appetite, Erythema, Eye pruritus, Headache, Heart rate decreased, Hypoaesthesia, Illness, Labyrinthitis, Meniscus injury, Mobility decreased, Muscle rupture, Otitis media, Pain, Product dose omission issue, Productive cough, SARS-CoV-2 test positive, Secretion discharge, Sneezing, Spinal pain, Stress, Throat irritation, Vertigo positional, Weight decreased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, PREDNISONE, PREDNISONE, MONTELUKAST SODIUM, MONTELUKAST SODIUM, ALBUTEROL SULFATE, |
||||
| 500 | 25067453 |
ES |
89 | 1 |
Erythema, Pruritus, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28